The digital diabetes management market share is expected to increase by USD 12.45 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 21.15%.

This digital diabetes management market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers digital diabetes management market segmentation by type (wearable devices and hand-held devices) and geography (North America, Europe, APAC, South America, and MEA). The digital diabetes management market report also offers information on several market vendors, including Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., Intel Corp., PHC Holdings Corp., and WaveForm Technologies Inc among others.

What will the Digital Diabetes Management Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Digital Diabetes Management Market Size for the Forecast Period and Other Important Statistics

Digital Diabetes Management Market: Key Drivers and Challenges

The rising global burden of diabetes is notably driving the digital diabetes management market growth, although factors such as stringent regulatory framework may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the digital diabetes management industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Digital Diabetes Management Market Driver

The global prevalence of the disease is increasing rapidly. It is projected that the number of diabetic patients will be doubled in the next 25 years. The growing incidence of type 1 and type 2 diabetes will significantly increase healthcare costs. The factors contributing to the increase in the diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. The incidence of diabetes is more in the case of the older population. Furthermore, the diabetic prevalence is high in European countries. Countries with a higher population base, such as China and India, are likely to have a higher incidence of diabetes due to increased obesity and urbanization factors. Thus, the increasing incidence of diabetes is likely to increase the adoption of digital diabetes management systems, which is expected to drive market growth. 

Key Digital Diabetes Management Market Challenge

Medical devices regulations must be improved to ensure high-quality, efficient, and safe technologies reach individuals. The growing number and modernization of medical devices have introduced new regulatory challenges. Vendors offering advanced digital diabetes management devices need to comply with the stringent regulatory scenario before its release into the market. The US FDA classified the diabetes care management devices such as insulin pumps, infusion sets, and insulin bolus under the Class II category. Failing to adhere to the US FDA regulations or causing complications would lead to the product's recall. A product recall will significantly affect the company's brand name. Thus, the vendors focusing on adopting innovative technologies and designing novel products should undergo stringent postmarket approvals before its launch. Therefore, the stringent regulatory scenario could potentially hamper the digital diabetes management market. 

This digital diabetes management market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Digital Diabetes Management Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• B. Braun Melsungen AG
• Becton Dickinson and Co.
• DarioHealth Corp.
• Dassault Systemes SE
• decide Clinical Software GmbH
• Dexcom Inc.
• Intel Corp.
• PHC Holdings Corp.
• WaveForm Technologies Inc

This statistical study of the digital diabetes management market encompasses successful business strategies deployed by the key vendors. The digital diabetes management market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The digital diabetes management market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Digital Diabetes Management Market?

For more insights on the market share of various regions Request for a FREE sample now!

48% of the market's growth will originate from North America during the forecast period. The US is a key market for digital diabetes management in North America. Market growth in North America will be faster than the growth of the market in other regions.

The increase in technological advances and a high incidence of type 1 and type 2 diabetes will facilitate the digital diabetes management market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Type Segments in the Digital Diabetes Management Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The digital diabetes management market share growth by the wearable devices segment will be significant during the forecast period. The increasing awareness among individuals about glucose monitoring and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery are the major factors driving the growth of the wearable devices segment. Moreover, growth in the number of regulatory approvals for CGM systems and the development of advanced wearable products such as closed-loop pump systems and smart insulin patches will further enhance the growth of the wearable devices segment of the global digital diabetes management market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the digital diabetes management market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Digital Diabetes Management Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive digital diabetes management market growth during the next five years
• Precise estimation of the digital diabetes management market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the digital diabetes management industry across North America, Europe, APAC, South America, and MEA
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of digital diabetes management market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch